Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 2/20 | 0.37 |
| ▸ | GRIN1 | Q05586 | 8/20 | 0.36 |
| ▸ | GRIN2B | Q13224 | 8/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | GPR139 | Q6DWJ6 | 5/20 | 0.34 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.34 |
| ▸ | ITGAV | P06756 | 1/20 | 0.34 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.34 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.34 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.34 |
| ▸ | JAK2 | O60674 | 1/20 | 0.33 |
| ▸ | JAK3 | P52333 | 1/20 | 0.33 |
| ▸ | EIF4EBP1 | Q13541 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31359077 | 1.00 | ELANE (0.37) | ELANEGRIN1GRIN2BKDM4EALDH1A1 | |
| SCHEMBL31359020 | 0.93 | GPR139 (0.39) | ELANEGRIN1GRIN2BKDM4EALDH1A1 | |
| SCHEMBL31359074 | 0.93 | GPR139 (0.39) | ELANEGRIN1GRIN2BKDM4EALDH1A1 | |
| SCHEMBL31359142 | 0.89 | KDM4E (0.37) | GRIN1GRIN2BKDM4EALDH1A1HPGD | |
| SCHEMBL31359025 | 0.89 | KDM4E (0.37) | GRIN1GRIN2BKDM4EALDH1A1HPGD | |
| SCHEMBL31359019 | 0.89 | PDPK1 (0.36) | GRIN1GRIN2BKDM4EALDH1A1HPGD | |
| SCHEMBL31161003 | 0.89 | PDPK1 (0.36) | GRIN1GRIN2BKDM4EALDH1A1HPGD | |
| SCHEMBL31359011 | 0.88 | GPR139 (0.35) | GRIN1GRIN2BKDM4EALDH1A1HPGD | |
| SCHEMBL31358984 | 0.88 | GPR139 (0.35) | GRIN1GRIN2BKDM4EALDH1A1HPGD | |
| SCHEMBL31160937 | 0.88 | ITGB1 (0.36) | GRIN1GRIN2BKDM4EALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12559464-B2 | Quinazolinone dione compounds and uses thereof | EDGEWISE THERAPEUTICS, INC. (US) | 2026-02-24 | — | — | US | disclosed |
| US-20250026726-A1 | QUINAZOLINONE DIONE COMPOUNDS AND USES THEREOF | EDGEWISE THERAPEUTICS, INC. | 2025-01-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250026726-A1 | QUINAZOLINONE DIONE COMPOUNDS AND USES THEREOF | TNNI3, TNNT2, MYLK2 | ELANE 3336/4885GRIN1 3327/4885GRIN2B 2743/4885 |
| US-12559464-B2 | Quinazolinone dione compounds and uses thereof | TNNI3, TNNT2, TNNC1 | ELANE 3301/4885GRIN1 1041/4885GRIN2B 596/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.